LHCSX Mutual Fund

NAV$23.44
Showing top 15 of 63 holdingsSee all 63 holdings(as of Apr 30, 2026)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgPROSectorPROIndustryPRO
1LLYEli Lilly And Company8.89%775$724.3K-Health CarePharmaceuticals
2AZN:LNAstrazeneca Plc Adr4.73%2,029$384.9K+183UnknownUnknown
3GILDGilead Sciences Inc4.25%2,647$346.3KProProPro
4JNJJOHNSON AND JOHNSON3.19%1,129$259.5KProProPro
5NKTRNektar Therapeutics3.17%3,038$258.4KProProPro
6NTRANatera Inc2.91%1,151$237.3KProProPro
7TARSTarsus Pharmaceuticals Inc2.83%3,622$230.4KProProPro
8GHGuardant Health Inccommon Stock2.63%2,459$214.1KProProPro
9ARGX:ASArgenx Se (Brussels Stock Exchange)2.49%259$203.1KProProPro
10NOVN:SMNovartis Ag Ordinary Shares2.46%1,356$200.4KProProPro
11CVSCvs Health Corp2.37%2,320$193.2KProProPro
12MDGLMadrigal Pharmaceuticals Inc2.22%350$181.1KProProPro
13ISRGIntuitive Surgical Inc - Common2.21%393$179.8KProProPro
14COGTCogent Biosciences Inc2.19%4,983$178.3KProProPro
15GALD:SMGalderma Group Ag - Common2.11%818$171.6KProProPro
See the other 48 holdings of LHCSX
Every position with sector, industry and share changes, as reported Apr 30, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

LHCSX Mutual Fund All Holdings

LHCSX holdings total 64 positions. The top 10 holdings account for 37.6% of the fund, led by Eli Lilly And Company at 8.9%, Astrazeneca Plc Adr at 4.7%, Gilead Sciences Inc at 4.3%.

LHCSX portfolio concentration is moderate, with the top 10 representing 37.6% of total assets. The largest sector exposure is Health Care at 80.2%.

LHCSX sector allocation provides a detailed breakdown. LHCSX overlap tool shows how holdings compare to other funds in your portfolio.